Atorvastatin and simvastatin in clinical management of high-risk patients
Aim. То assess the use of average therapeutic doses of atorvastatin and simvastatin (Torvacard and Simvacard) in real-world clinical management of high-risk patients.Material and methods. The study included 347 doctors from 30 Russian cities and 1163 high-risk patients randomised into two groups: To...
Saved in:
| Main Authors: | S. A. Shalnova, A. D. Deev |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
«SILICEA-POLIGRAF» LLC
2009-02-01
|
| Series: | Кардиоваскулярная терапия и профилактика |
| Subjects: | |
| Online Access: | https://cardiovascular.elpub.ru/jour/article/view/1152 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Double cholesterol inhibition — a new approach to effective control of hyperlipidemia and atherosclerosis
by: A. V. Susekov, et al.
Published: (2009-12-01) -
EFFECT OF SIMVASTATIN ON MARKERS OF CARDIOVASCULAR RISK
by: N. V. Perova, et al.
Published: (2016-01-01) -
RATIONAL APPROACHES TO THE TREATMENT OF DYSLIPIDEMIA WITH DIFFERENT TOTAL CARDIOVASCULAR RISK AND ACUTE CORONARY SYNDROME
by: N. V. Perova, et al.
Published: (2015-09-01) -
Familial hypercholesterolemia: current status of the problem, treatment, and prevention
by: S. A. Bliznyuk, et al.
Published: (2020-11-01) -
Studying the Possibility of Optimizing the Statin Therapy Algorithm in Outpatient Practice
by: D. V. Nebieridze, et al.
Published: (2020-09-01)